RT Journal Article
T1 Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change?
A1 Jimenez-Ubieto, Ana
A1 Paiva, Bruno
A1 Puig, Noemi
A1 Cedena, Maria-Teresa
A1 Martinez-Lopez, Joaquin
A1 Oriol, Albert
A1 Blanchard, Maria-Jesus
A1 Rios, Rafael
A1 Martin, Jesus
A1 Martinez, Rafael
A1 Sureda, Anna
A1 Hernandez, Miguel-Teodoro
A1 de la Rubia, Javier
A1 Krnisk, Isabel
A1 Cabanas, Valentin
A1 Palomera, Luis
A1 Sanchez-Pina, Jose Maria
A1 Bargay, Joan
A1 Mateos, Maria-Victoria
A1 Rosinol, Laura
A1 Blade, Joan
A1 San Miguel, Jesus
A1 Lahuerta, Juan Jose
A1 GEM Grp Espanol Mieloma, 
A1 PETHEMA Programa Espanol Tratam, 
K1 Minimal residual disease
K1 Multiple-myeloma
K1 Transplantation
K1 Bortezomib
K1 Therapy
PB Amer soc hematology
SN 0006-4971
YR 2021
FD 2021-11-11
LK https://hdl.handle.net/10668/26424
UL https://hdl.handle.net/10668/26424
LA en
DS RISalud
RD Apr 19, 2025